Article
Enhancing bacteriophage therapeutics through <i>in situ</i> production and release of heterologous antimicrobial effectors
2022-03-09
Abstract excerpt
Bacteriophages operate via pathogen-specific mechanisms of action distinct from conventional, broad-spectrum antibiotics and are emerging as promising alternatives. However, phage-mediated killing is often limited by bacterial resistance development (1,2). Here, we engineer phages for target-specific effector gene delivery and host-dependent production of colicin-like bacteriocins and cell wall hydrolases. Using u...
Topics
Open a Topic to create a Post that cites this publication.
- Bacteriophages and microbial interactions
- CRISPR and Genetic Engineering
- Enterobacteriaceae and Cronobacter Research
- Escherichia coli research studies
- Microbial infections and disease research
- Monoclonal and Polyclonal Antibodies Research
- Polyomavirus and related diseases
- Urinary Tract Infections Management
Identifiers and source
- Literature Corpus work
- 41dc4042-5e42-5982-934c-4fc0fa511a0f
- DOI
- 10.1101/2022.03.09.483629
